Company registration number SC258396 (Scotland)
BIRCH LEAF (EUROPE) LTD (FORMERLY SYNERGEN PHARMA DEVELOPMENT LIMITED)
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2024
PAGES FOR FILING WITH REGISTRAR
BIRCH LEAF (EUROPE) LTD (FORMERLY SYNERGEN PHARMA DEVELOPMENT LIMITED)
Balance Sheet
As At 31 October 2024
- 1 -
2024
2023
£
£
£
£
Fixed assets
475
-
0
Current assets
29,781
394
Creditors: amounts falling due within one year
(46,448)
(41,174)
Net current liabilities
(16,667)
(40,780)
Total assets less current liabilities
(16,192)
(40,780)
Accruals and deferred income
(3,650)
(250)
Net liabilities
(19,842)
(41,030)
Capital and reserves
(19,842)
(41,030)
Notes to the financial statements
1
Employees

The average number of persons, including directors, employed by the company during the year was as follows:

2024
2023
Number
Number
Employees
1
0

Birch Leaf (Europe) Ltd (formerly Synergen Pharma Development Limited) is a private company limited by shares incorporated in Scotland. The registered office is 1 George Square, Castle Brae, Dunfermline, Fife, KY11 8QF.

For the year ended 31 October 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime', and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

BIRCH LEAF (EUROPE) LTD (FORMERLY SYNERGEN PHARMA DEVELOPMENT LIMITED)
Balance Sheet (Continued)
As At 31 October 2024
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 27 October 2025 and are signed on its behalf by:
Mr G J Birrell
Director
Company registration number SC258396 (Scotland)
2024-10-312023-11-01falsefalseCCH SoftwareCCH Accounts Production 2025.300No description of principal activityMr G J BirrellMrs L A BirrellPurple Venture Secretaries LimitedfalseSC2583962023-11-012024-10-31SC2583962024-10-31SC2583962023-10-31SC258396core:CurrentFinancialInstrumentscore:WithinOneYear2024-10-31SC258396core:CurrentFinancialInstrumentscore:WithinOneYear2023-10-31SC2583962022-11-012023-10-31SC258396bus:Director12023-11-012024-10-31SC258396bus:PrivateLimitedCompanyLtd2023-11-012024-10-31SC258396bus:SmallCompaniesRegimeForAccounts2023-11-012024-10-31SC258396bus:Micro-entities2023-11-012024-10-31SC258396bus:AuditExemptWithAccountantsReport2023-11-012024-10-31SC258396bus:Director22023-11-012024-10-31SC258396bus:CompanySecretary12023-11-012024-10-31SC258396bus:FullAccounts2023-11-012024-10-31xbrli:purexbrli:sharesiso4217:GBP